These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

911 related articles for article (PubMed ID: 27858115)

  • 1. [The new ESC Guidelines for acute and chronic heart failure 2016].
    Oeing CU; Tschöpe C; Pieske B
    Herz; 2016 Dec; 41(8):655-663. PubMed ID: 27858115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Contemporary epidemiology and treatment of hospitalized heart failure patients in real clinical practice in China].
    Wang H; Li YY; Chai K; Zhang W; Li XL; Dong YG; Zhou JM; Huo Y; Yang JF
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Nov; 47(11):865-874. PubMed ID: 31744275
    [No Abstract]   [Full Text] [Related]  

  • 3. [Guidelines of the ESC 2021 on heart failure].
    Bauersachs J; Soltani S
    Herz; 2022 Feb; 47(1):12-18. PubMed ID: 34825250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry.
    Chioncel O; Lainscak M; Seferovic PM; Anker SD; Crespo-Leiro MG; Harjola VP; Parissis J; Laroche C; Piepoli MF; Fonseca C; Mebazaa A; Lund L; Ambrosio GA; Coats AJ; Ferrari R; Ruschitzka F; Maggioni AP; Filippatos G
    Eur J Heart Fail; 2017 Dec; 19(12):1574-1585. PubMed ID: 28386917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry.
    Maggioni AP; Anker SD; Dahlström U; Filippatos G; Ponikowski P; Zannad F; Amir O; Chioncel O; Leiro MC; Drozdz J; Erglis A; Fazlibegovic E; Fonseca C; Fruhwald F; Gatzov P; Goncalvesova E; Hassanein M; Hradec J; Kavoliuniene A; Lainscak M; Logeart D; Merkely B; Metra M; Persson H; Seferovic P; Temizhan A; Tousoulis D; Tavazzi L;
    Eur J Heart Fail; 2013 Oct; 15(10):1173-84. PubMed ID: 23978433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute and chronic heart failure in light of the new ESC guidelines].
    Pöss J; Link A; Böhm M
    Herz; 2013 Dec; 38(8):812-20. PubMed ID: 24146139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of expanding evidence and evolving clinical guidelines on the prevalence of indication for cardiac resynchronization therapy in patients with heart failure.
    Lund LH; Svennblad B; Dahlström U; Ståhlberg M
    Eur J Heart Fail; 2018 Apr; 20(4):769-777. PubMed ID: 28949083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the pharmacological therapy of chronic heart failure: Evidence and guidelines.
    Tsutsui H
    Pharmacol Ther; 2022 Oct; 238():108185. PubMed ID: 35413307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to ESC cardiac resynchronization therapy guidelines: findings from the ESC CRT Survey II.
    Normand C; Linde C; Blomström-Lundqvist C; Stellbrink C; Gasparini M; Anker SD; Plummer C; Sarigul NU; Papiashvili G; Iovev S; Dickstein K
    Europace; 2020 Jun; 22(6):932-938. PubMed ID: 32330937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart Failure Society of South Africa (HeFSSA) perspective on the European Society of Cardiology (ESC) 2012 chronic heart failure guideline.
    Mpe MT; Klug EQ; Silwa KS; Hitzeroth J; Smith DA
    S Afr Med J; 2013 Jul; 103(9 Suppl 2):660-7. PubMed ID: 24300688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular ejection fraction as therapeutic target: is it the ideal marker?
    Katsi V; Georgiopoulos G; Laina A; Koutli E; Parissis J; Tsioufis C; Nihoyannopoulos P; Tousoulis D
    Heart Fail Rev; 2017 Nov; 22(6):641-655. PubMed ID: 28601914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients.
    Kosztin A; Kutyifa V; Nagy VK; Geller L; Zima E; Molnar L; Szilagyi S; Ozcan EE; Szeplaki G; Merkely B
    Europace; 2016 Apr; 18(4):550-9. PubMed ID: 26116830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal effects of guideline-directed medical therapies in heart failure: a consensus document from the Heart Failure Association of the European Society of Cardiology.
    Mullens W; Martens P; Testani JM; Tang WHW; Skouri H; Verbrugge FH; Fudim M; Iacoviello M; Franke J; Flammer AJ; Palazzuoli A; Barragan PM; Thum T; Marcos MC; Miró Ò; Rossignol P; Metra M; Lassus J; Orso F; Jankowska EA; Chioncel O; Milicic D; Hill L; Seferovic P; Rosano G; Coats A; Damman K
    Eur J Heart Fail; 2022 Apr; 24(4):603-619. PubMed ID: 35239201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart failure in patients with coronary heart disease: Prevalence, characteristics and guideline implementation - Results from the German EuroAspire IV cohort.
    Morbach C; Wagner M; Güntner S; Malsch C; Oezkur M; Wood D; Kotseva K; Leyh R; Ertl G; Karmann W; Heuschmann PU; Störk S
    BMC Cardiovasc Disord; 2017 May; 17(1):108. PubMed ID: 28476146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is heart failure misdiagnosed in hospitalized patients with preserved ejection fraction? From the European Society of Cardiology - Heart Failure Association EURObservational Research Programme Heart Failure Long-Term Registry.
    Kapłon-Cieślicka A; Laroche C; Crespo-Leiro MG; Coats AJS; Anker SD; Filippatos G; Maggioni AP; Hage C; Lara-Padrón A; Fucili A; Drożdż J; Seferovic P; Rosano GMC; Mebazaa A; McDonagh T; Lainscak M; Ruschitzka F; Lund LH;
    ESC Heart Fail; 2020 Oct; 7(5):2098-2112. PubMed ID: 32618139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACC/AHA Versus ESC Guidelines on Heart Failure: JACC Guideline Comparison.
    van der Meer P; Gaggin HK; Dec GW
    J Am Coll Cardiol; 2019 Jun; 73(21):2756-2768. PubMed ID: 31146820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The stricter criteria for Class I CRT indication suggested by the 2016 ESC Guidelines reliably exclude patients with a worse prognosis in comparison with the 2013 ESC indication criteria.
    Bertaglia E; Reggiani A; Palmisano P; D'Onofrio A; De Simone A; Caico SI; Pecora D; Arena G; Marini M; Ricciardi G; Badolati S; Spotti A; Solimene F; Ferraro A; Migliore F; Botto GL; Malacrida M; Stabile G
    Int J Cardiol; 2018 Dec; 273():162-167. PubMed ID: 30217421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Who are patients classified within the new terminology of heart failure from the 2016 ESC guidelines?
    Delepaul B; Robin G; Delmas C; Moine T; Blanc A; Fournier P; Roger-Rollé A; Domain G; Delon C; Uzan C; Boudjellil R; Carrié D; Roncalli J; Galinier M; Lairez O
    ESC Heart Fail; 2017 May; 4(2):99-104. PubMed ID: 28451445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases.
    Sirithunyanont C; Leowattana W; Sukumalchantra Y; Chaisupamonkollarp S; Watanawaroon S; Chivatanaporn B; Bhuripanyo K; Mahanonda N
    J Med Assoc Thai; 2003 May; 86 Suppl 1():S87-95. PubMed ID: 12866774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do cardiologists follow the European guidelines for cardiac pacing and resynchronization therapy? Results of the European Heart Rhythm Association survey.
    Sciaraffia E; Dagres N; Hernandez-Madrid A; Proclemer A; Todd D; Blomström-Lundqvist C
    Europace; 2015 Jan; 17(1):148-51. PubMed ID: 25552672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.